Content hub
Explore private capital market trends, in-depth research from leading industry partners, expert interviews, live webinars, and educational videos — all in one place.
Featured Article
Private Credit Defaults 101: Back to School
As Labor Day approaches, the unofficial end of summer is upon us. But, before we get too sad, there is also the familiar back-to-school energy.
|
September 2, 2026 
Private Debt Intelligence - 10/30/2023
Tracking the number of new participants in private debt [wpdm_package id=’67050′] This year will see the most US first-time funds…
ABL Deep Dive: Numbers don't tell entire story
Over US$126bn in asset based loan volume was completed in 1-3Q23 which at first glance suggests record total for the…
Loan Stats at a Glance - 10/30/2023
Source: Pitchbook LCDContact: Marina Lukatskymarina.lukatsky@pitchbook.com
No Stopping This Show
Though a slowdown for 4Q and 1Q 2024 is expected, the US economy shows few signs of it. Source: The…
A big drop in mega-buyouts
Download PitchBook’s Report here. $1B+ deals are set for a big decline this year, according to PitchBook’s Q3 US PE Breakdown. Through Q3,…
Middle Market & Private Credit – 10/23/2023
U.S. Middle Market CLOs’ ‘CCC’ Exposure Rising in Third Quarter Negative rating migration has increased the average exposure to assets…
Letter from Stockholm
Our recent visit to Sweden was the 12th country in our 2023 global private credit tour meeting clients and prospects.…
Debtwire Middle-Market – 10/23/2023
Repricings tick upward in opportune window An upturn in repricing transactions has been seen in the leveraged loan market over…
What’s next for distress?
PDI’s Germany Forum examined the upcoming opportunity set for distressed and special situations as a refinancing wave looms. “This is…
US market unitranche spreads decreased in 3Q23
In 3Q23, US unitranche blended spreads declined for the second straight quarter. The average unitranche blended spread, including both middle…
Percentage of Loans with F&C Tranche Growers
(Past performance is no guarantee of future results.) Contact: Steven Miller
Novo Nordisk Effect
Blockbuster drugs Ozempic and Wegovy are driving Denmark’s manufacturing production. Source: Apricitas Economics(Past performance is no guarantee of future results.)
Private Debt Intelligence - 10/23/2023
Private debt dry powder at all time high [wpdm_package id=’66940′] The post-pandemic monetary environment has spurred the growth of the…
Middle Market Deal Terms at a Glance - October 2023
Source: SPP Capital Partners Contact: Stefan Shaffersshaffer@sppcapital.com
No Signs of Slowing (Except Defaults)
Since Labor Day we’ve spent considerable time at conferences and with investors. Nothing focuses the mind better. And what we’ve…